mb1 vs glp 1 Bariatric Surgery vs. GLP-1 Drugs | Garnet Health | Mid-Hudson Healthcare System 💉 GLP-1 vs GLP-1/GIP: What's

Hargrove DM, Kendall ES, Reynolds JM, et al

However, Thursdays FDA announcement effectively puts an end to that, and compounding pharmacies must now cease producing the lucrative drugs within a set time period

Patients with established cardiovascular disease Those with previous myocardial infarction, stroke, or peripheral arterial disease may benefit from the cardioprotective effects of certain GLP-1 receptor agonists, which include modest blood pressure reductions alongside other cardiovascular benefits

GLP-1 receptor agonists are incretin-based therapies that: Enhance glucose-dependent insulin secretion Suppress glucagon release Slow gastric emptying Promote satiety and weight loss Common medications include: Semaglutide Tirzepatide Dulaglutide Liraglutide Their ability to delay gastric emptying is central to both their therapeutic benefits and perioperative risks

The biggest safety worry is that these compounded versions of small amounts of medication are not FDA-approved

GLP-1 drugs have been approved by the FDA for diabetes and weight loss, making way for GLP-1 patches for both indications